Interview with Zbigniew Pawlowski, president of the Association of Families of Patients with Amyloidosis.
For the treatment of transthyretin amyloidosis, we have registered causal treatment. What is the availability of this therapy for patients in Poland?
In cardiac amyloidosis, we have re...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
